Search

everythinglearnresearchcommunity

for

Search:↓

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Alopecia areata patients often have eczema, thyroid issues, vitamin-D deficiency, and anemia.

People with Alopecia Areata have lower vitamin D levels.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Prednisone may cause multiple skin nodules in lupus patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

People with atopic dermatitis have a higher risk of developing keloids, especially women, those under 40, and those with severe symptoms.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Higher aldosterone levels link to hair loss and high blood pressure.